BioNTech SE (BNTX) Cash from Investing Activities (QoQ) (2019 - 2024)
BioNTech SE (BNTX) Cash from Investing Activities (QoQ) (2019 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
BioNTech SE |
27.38 Bn |
10.07 Bn |
668.28 Mn |
| Date | Value |
|---|
| Dec 31, 2024 |
515.44% |
| Sep 30, 2024 |
39.97% |
| Jun 30, 2024 |
89.62% |
| Mar 31, 2024 |
13.67% |
| Dec 31, 2023 |
-116.18% |
| Sep 30, 2023 |
46.25% |
| Jun 30, 2023 |
-216.16% |
| Mar 31, 2023 |
-580.54% |
| Dec 31, 2021 |
135.79% |
| Sep 30, 2021 |
35.06% |
| Jun 30, 2021 |
5.13% |
| Mar 31, 2021 |
28,688,303.03% |
| Dec 31, 2020 |
-100.00% |
| Sep 30, 2020 |
119.67% |
| Jun 30, 2020 |
-34.38% |
| Mar 31, 2020 |
110.30% |
| Dec 31, 2019 |
-774.29% |
| Sep 30, 2019 |
67.28% |
| Jun 30, 2019 |
-62.45% |
| Mar 31, 2019 |
171.69% |
